Top Companies in Non-Invasive Prenatal Testing Market

The global non-invasive prenatal testing market size reached USD 4.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.4 Billion by 2033, exhibiting a CAGR of 13.85% during 2025-2033. The leading players operating in the non-invasive prenatal testing market are experiencing lucrative opportunities on account of technological advancements in life sciences and the healthcare industry.

Besides this, the increasing maternal age, which is associated with fatal pregnancy complications, including the high risk of miscarriage, in confluence with the increasing preference for non-invasive methods, is positively influencing the demand for non-invasive prenatal testing worldwide. The market's strong growth is supported by a range of fundamental demand drivers such as increasing healthcare infrastructure and insurance coverage for genetic testing services, increasing physician and patient education and awareness of NIPT advantage over conventional invasive methods, and increasing focus on personalized medicine and precision healthcare strategies.

In addition, advances in next-generation sequencing, cell-free DNA testing, and bioinformatics have enhanced test performance and decreased cost, making NIPT more widely available to larger patient groups. The COVID-19 pandemic has further fueled adoption as health care providers and patients move to limit hospital encounters and decrease exposure risks with invasive procedures, while regulatory approvals and clinical recommendations increasingly favor NIPT inclusion into routine prenatal care pathways.

Request Free Sample Report: https://www.imarcgroup.com/non-invasive-prenatal-testing-market/requestsample

World's Largest Non-Invasive Prenatal Testing Companies Operating in the Market:

The top manufacturers in the global non-invasive prenatal testing market have several major players including Berry Genomics, BGI, CENTOGENE GmbH, Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche Ltd, Igenomix, Illumina, Inc., Laboratory Corporation of America Holdings, MedGenome, Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Yourgene Health.

1. Berry Genomics

Establishment:	2010
Headquarters:	Beijing, China
Website:	https://www.berrygenomics.com/

 

Berry Genomics Co. Ltd. is one of the leading companies in clinical genomics and life science. The company is mainly focusing on the research, development and commercialization of genetic test technologies in clinical applications. It focuses on improving human health and helping accurate diagnosis of diseases throughout the full human life circle. It offers NGS- based tests for many genetic diseases and cancers from preconception to adulthood.

2. BGI

Establishment:	1991
Headquarters:	Shenzhen, China
Website:	https://www.bgi.com

 

BGI Genomics Co., Ltd. is a leading provider of genomic sequencing services and proteomic services. The company provides academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing and proteomic services and solutions across more than 66 countries. It also recently offered ‘Huo-Yan’ laboratory solution that allowed rapid detection and diagnosis of patients suspected of COVID-19.

3. CENTOGENE GmbH

Establishment:	2006
Headquarters:	Rostock, Germany
Website:	https://www.centogene.com/

CENTOGENE GmbH is a commercial-stage organization specializing in rare diseases that translates real-world genetic and clinical information into actionable insights for patients, physicians, and pharmaceutical organizations. The prenatal diagnostics business segment takes advantage of their vast experience in rare diseases to provide detailed NIPT services that cover screening for chromosomal defects and rare genetic disorders. CENTOGENE's technology platform integrates next-generation sequencing, cutting-edge bioinformatics, and large genetic databases to deliver precise and extensive prenatal screening solutions. Its international coverage spans alliances with healthcare professionals and labs on several continents, making available advanced genetic testing services on a broad scale.

4. Eurofins LifeCodexx GmbH

Establishment:	2010
Headquarters:	Konstanz, Germany
Website:	https://lifecodexx.com/

 

Eurofins LifeCodexx GmbH is developing innovative and clinically validated non-invasive diagnostic tests on the basis of the newest molecular analytical methods. The company has been relying on PrenaTest®, Europe’s first non-invasive prenatal test (NIPT), for determining the most common chromosomal disorders in unborn children. This test is performed in Germany following strict conformity of the highest quality standards as per the European Directive on In-vitro Diagnostic Medical Devices.

5. F. Hoffmann-La Roche Ltd

Establishment:	1896
Headquarters:	Basel, Switzerland
Website:	https://www.roche.com/

 

F. Hoffmann-La Roche Ltd. Introduces innovative medicines and diagnostic tests that help patients across the globe. Using its strength in pharmaceuticals and diagnostics, the company focuses on offering personalized healthcare facilities. Moreover, around two-thirds of the research and development (R&D) projects are developed with companion diagnostics.

6. Igenomix

Establishment:	2011
Headquarters:	Valencia, Spain
Website:	https://www.igenomix.com/

 

Igenomix operates as a medical testing laboratory specializing in reproductive genetic services. The company offers services, including Non-Invasive Prenatal Test, Carrier Genetic Test, Preimplantation Genetic Diagnosis, and Endometrial Receptivity Array. It also offers pioneering tests to aid reproductive health professionals to diagnose as well as treat their patients. 

7. Illumina, Inc.

Establishment:	1998
Headquarters:	San Diego, California, USA
Website:	https://www.illumina.com/

Illumina, Inc. is one of the leaders in genomics that strives to make our solutions increasingly simple, more accessible, and reliable. The objective of the company is to employ innovative technologies for the analysis of genetic variation and function, thereby making studies possible that were unimaginable earlier. It focuses on delivering innovative, flexible, and scalable solutions to meet the needs of the customers.

8. Laboratory Corporation of America Holdings

Establishment:	1978
Headquarters:	Burlington, North Carolina, USA
Website:	https://www.labcorp.com/

 

Laboratory Corporation of America Holdings has one of the world’s most advanced testing potential. The company primarily operates with the objective of improving the health and lives of individuals around the world. It is managing to support clinical trial research efforts in more than 100 countries.

9. MedGenome

Establishment:	2013
Headquarters:	Bangalore, India
Website:	https://diagnostics.medgenome.com/

MedGenome is a pioneer genomics and precision medicine firm that focuses on genetic testing and research services, with non-invasive prenatal testing as its flagship clinical product. The firm utilizes next-generation genomic technologies and bioinformatics expertise to deliver extensive NIPT solutions that identify chromosomal abnormalities and genetic conditions with high sensitivity. MedGenome's prenatal testing suite consists of routine chromosomal screening, extended panels of genetic tests, and rare genetic disease-specific testing on next-generation sequencing and sophisticated analysis platforms. Their technological capabilities encompass in-house bioinformatics pipelines, exhaustive genetic databases, and quality assurance programs that provide consistent test performance in heterogeneous patient populations. They cater to healthcare providers in India and global markets, with developed partnerships that increase access to sophisticated genetic testing services.

10. Myriad Genetics, Inc.

Establishment:	1991
Headquarters:	Salt Lake City, Utah, USA
Website:	https://myriad.com/

Myriad Genetics, Inc. is a molecular diagnostics business with a specialization in genetic testing and targeted medicine with non-invasive prenatal testing forming a central component of their overall reproductive health portfolio. The company uses decades of genetic testing experience, along with proprietary technologies, to offer advanced NIPT solutions that provide accurate and reliable screening for chromosomal abnormalities and inherited genetic disorders. Myriad's prenatal testing entails comprehensive chromosomal screening, single-gene disease detection, and comprehensive genetic testing on the basis of proven laboratory platforms and sophisticated bioinformatics infrastructure. Their groundbreaking technologies consist of proprietary testing technology, sophisticated quality control tools, and comprehensive genetic interpretation capabilities that enhance test accuracy and clinical utility.

11. Natera, Inc.

Establishment:	2004
Headquarters:	Austin, Texas, USA
Website:	https://www.natera.com/

Natera, Inc. is a global leader in cell-free DNA (cfDNA) testing with a prime focus on the health, oncology, and organ health of women. The company has pioneered non-invasive blood-based testing in the fields of women’s health, oncology, and organ health. It is also exploring new approaches to managing genetic testing.

12. Quest Diagnostics Incorporated

Establishment:	1967
Headquarters:	Secaucus, New Jersey, USA
Website:	https://www.questdiagnostics.com/

Quest Diagnostics Incorporated is a worldwide leader in offering diagnostic testing, information, and services utilizing their extensive network of laboratories and advanced genetic testing. The organization provides comprehensive non-invasive prenatal testing solutions using their extensive laboratory network and advanced genetic testing capabilities. The company provides a full suite of NIPT testing services including chromosomal screening, detection of genetic disorders, and specialized prenatal test panels that serve different patient populations and healthcare professionals. The technology infrastructure of Quest includes next-generation sequencing platforms, medical laboratory automation systems, and advanced data management features that deliver high-quality testing services and efficient results delivery. Their extensive network of patient service centers and provider connections offer widespread access to high-end prenatal genetic testing services across different geographic markets.

13. Thermo Fisher Scientific Inc.

Establishment:	2006
Headquarters:	Waltham, Massachusetts, USA
Website:	https://www.thermofisher.com/in/en/home.html

Thermo Fisher Scientific Inc. is a worldwide leader in serving science and healthcare by delivering critical technologies, reagents, and services that make non-invasive prenatal testing possible throughout the healthcare industry. Thermo Fisher's full portfolio consists of sequencing platforms, laboratory automation systems, reagent kits, and bioinformatics solutions that assist NIPT laboratories globally. Thermo Fisher's technological advancements encompass novel sequencing chemistry, automated library preparation instruments, and integrated analysis software that improve testing accuracy, efficiency, and volume. Its international manufacturing and distribution networks guarantee secure supply of essential testing components and technologies to healthcare providers and diagnostic laboratories globally. It has strategic alliances with clinical laboratories, diagnostic companies, and research institutions whose technological infrastructure supports widening prenatal genetic testing services.

14. Yourgene Health

Establishment:	2013
Headquarters:	Manchester, United Kingdom
Website:	https://yourgenehealth.com/

Yourgene Health Plc is an international molecular diagnostics company that develops and commercializes genetic products and services. The company works in partnership with global leaders in DNA technology to advance diagnostic science. It mainly develops, manufactures, and commercializes simple and accurate molecular diagnostic solutions.

About IMARC Group: IMARC Group is a leading market research and consulting company that offers management strategy and market research worldwide. The company has done multiple projects on the global non-invasive prenatal testing market, which has enabled the clients to set up and expand their businesses successfully. Some of the company’s offerings include:

• Market Research
• Plant Setup
• Plant Expansion
• Marketing and Sales
• Procurement and Distribution
• Innovation and Product Development